List of Tables
    Table 1. Pemetrexed Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Pemetrexed Drug Market Trends
    Table 3. Pemetrexed Drug Market Drivers
    Table 4. Pemetrexed Drug Market Challenges
    Table 5. Pemetrexed Drug Market Restraints
    Table 6. Global Pemetrexed Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pemetrexed Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pemetrexed Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pemetrexed Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pemetrexed Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pemetrexed Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Pemetrexed Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Pemetrexed Drug Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Pemetrexed Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Pemetrexed Drug Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Pemetrexed Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Pemetrexed Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Drug as of 2021)
    Table 18. Top Players of Pemetrexed Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Pemetrexed Drug Product Type
    Table 20. Date of International Manufacturers Enter into Pemetrexed Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Pemetrexed Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Pemetrexed Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Pemetrexed Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Pemetrexed Drug Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Pemetrexed Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Pemetrexed Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Pemetrexed Drug Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Pemetrexed Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Pemetrexed Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Pemetrexed Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Pemetrexed Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Pemetrexed Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Pemetrexed Drug Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Pemetrexed Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Pemetrexed Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Pemetrexed Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Pemetrexed Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Pemetrexed Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Pemetrexed Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Pemetrexed Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Eli Lilly and Company Corporation Information
    Table 43. Eli Lilly and Company Description and Business Overview
    Table 44. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Eli Lilly and Company Pemetrexed Drug Product
    Table 46. Eli Lilly and Company Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Teva Corporation Information
    Table 53. Teva Description and Business Overview
    Table 54. Teva Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Teva Product
    Table 56. Teva Recent Development
    Table 57. Eagle Pharmaceuticals Corporation Information
    Table 58. Eagle Pharmaceuticals Description and Business Overview
    Table 59. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Eagle Pharmaceuticals Product
    Table 61. Eagle Pharmaceuticals Recent Development
    Table 62. APOTEX Corporation Information
    Table 63. APOTEX Description and Business Overview
    Table 64. APOTEX Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. APOTEX Product
    Table 66. APOTEX Recent Development
    Table 67. Qilu Pharmaceutical Corporation Information
    Table 68. Qilu Pharmaceutical Description and Business Overview
    Table 69. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Qilu Pharmaceutical Product
    Table 71. Qilu Pharmaceutical Recent Development
    Table 72. Biocon Corporation Information
    Table 73. Biocon Description and Business Overview
    Table 74. Biocon Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Biocon Product
    Table 76. Biocon Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. Pemetrexed Drug Customers List
    Table 80. Pemetrexed Drug Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pemetrexed Drug Product Picture
    Figure 2. Global Pemetrexed Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pemetrexed Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Pemetrexed Drug Sales 2017-2028 (K Units)
    Figure 5. United States Pemetrexed Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Pemetrexed Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Pemetrexed Drug Sales 2017-2028 (K Units)
    Figure 8. United States Pemetrexed Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Pemetrexed Drug Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Pemetrexed Drug Report Years Considered
    Figure 11. Product Picture of 100 mg lyophilized powder/vial
    Figure 12. Product Picture of 500 mg lyophilized powder/vial
    Figure 13. Global Pemetrexed Drug Market Share by Type in 2022 & 2028
    Figure 14. Global Pemetrexed Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Pemetrexed Drug Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Pemetrexed Drug Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Pemetrexed Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Pemetrexed Drug Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Pemetrexed Drug Market Share by Type in 2022 & 2028
    Figure 20. United States Pemetrexed Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Pemetrexed Drug Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Pemetrexed Drug Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Pemetrexed Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Pemetrexed Drug Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Pleural mesothelioma
    Figure 26. Product Picture of Non-small cell lung cancer
    Figure 27. Global Pemetrexed Drug Market Share by Application in 2022 & 2028
    Figure 28. Global Pemetrexed Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Pemetrexed Drug Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Pemetrexed Drug Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Pemetrexed Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Pemetrexed Drug Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States Pemetrexed Drug Market Share by Application in 2022 & 2028
    Figure 34. United States Pemetrexed Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Pemetrexed Drug Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Pemetrexed Drug Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Pemetrexed Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Pemetrexed Drug Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America Pemetrexed Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Pemetrexed Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Pemetrexed Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Pemetrexed Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Pemetrexed Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Pemetrexed Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Pemetrexed Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Pemetrexed Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Pemetrexed Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Pemetrexed Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Pemetrexed Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Pemetrexed Drug Value Chain
    Figure 73. Pemetrexed Drug Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed